Evidence map›Paper›PMID 24031169›Full record

ArticleBrazilian journal of microbiology : [publication of the Brazilian Society for Microbiology]2008

Comparative evaluation of the Nitrate Reductase Assay and the Resazurin Microtitre Assay for drug susceptibility testing of Mycobacterium tuberculosis against first line anti-tuberculosis drugs.

Karine O Sanchotene, Andrea von Groll, Daniela Ramos, Ana B Scholante, Gunther Honscha, Mariana Valença, Carlos J Scaini, Pedro E A da Silva

Open access · hybridAbstract read
In one paragraph

Article in Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology], 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Antifungal activity of isolated compounds from CTurkish journal of chemistry · 2026
    Article
  3. Article
  4. Article
  5. Measuring of Mycobacterium tuberculosis growth. A correlation of the optical measurements with colony forming units.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2013
    Article
  6. Article
  7. Nitrate reductase assay using sodium nitrate for rapid detection of multidrug resistant tuberculosis.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2012
    Article
  8. Growth kinetics of Mycobacterium tuberculosis measured by quantitative resazurin reduction assay: a tool for fitness studies.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2010
    Article
  9. Characterization of Mycobacterium tuberculosis complex isolated from iranian and afghani patients by spoligotyping method.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2009
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Karine O SanchoteneLaboratório de Micobactérias, Departamento de Patologia, Fundação Universidade Federal do Rio Grande , Rio Grande, RS , Brasil ; Laboratório de Biologia Molecular, Departamento de Patologia, Fundação Universidade Federal do Rio Grande , Rio Grande, RS , Brasil.
Andrea von Groll
Daniela Ramos
Ana B Scholante
Gunther Honscha
Mariana Valença
Carlos J Scaini
Pedro E A da Silva
Universidade Federal do Rio Grande · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tuberculosis remains as a serious infection disease of worldwide distribution, with high morbidity and mortality, mainly in low socio-economic condition countries. The state of emergency of tuberculosis caused by the resistant and multidrug-resistant (MDR) strains, became the main threat to the tuberculosis treatment and control programs. A fast detection method for the resistant strains will allow the implementation of an adequate treatment and contribute for controlling the dissemination of these resistant strains. This study evaluated the performance of the nitrate reductase assay in solid (NRA-LJ) and liquid (NRA-7H9) media, to determine the susceptibility to first line anti-tuberculosis drugs: isoniazid (INH), rifampicin (RMP), ethambutol (EMB) and streptomycin (SMR). Both methods NRA-LJ and NRA-7H9 were evaluated among 18 strains with a known susceptibility profile. The resazurin microtiter assay (REMA) was performed as a reference method. One hundred percent of accordance was observed between NRA-7H9 and REMA for the four tested drugs. When the NRA-LJ method was compared to REMA, the sensitivity and the specificity to INH, RMP, EMB and SMR were 100%, 100 %, 85.7%, 76.9% and 80%, 100%, 75% and 80%, respectively. From the 57 clinical isolates of M. tuberculosis evaluated by NRA-7H9 and REMA, 56 (98.2%) were sensitive to all antibiotics tested (INH, RMP, EMB and SMR) by the NRA-7H9 method, while three of these strains were resistant to INH by REMA. One strain showed resistance to INH and RMP for both methods, and MIC of 1.0 μg/ml to INH for both methods, while MIC of 1.0 and 2.0 μg/ml to RMP for REMA and NRA-7H9, respectively. The three assays showed a high level of agreement for rapid detection of rifampicin and isoniazid resistance. Regarding rapidness, the detection of color change in the NRA method is within instants as compared to the overnight incubation required for the REMA test. NRA might represent an inexpensive and alternative assay for rapid detection of resistance in low-income countries.

Indexed as

drug resistanceMycobacterium tuberculosisNitrate reductase assaysusceptibility testsTuberculosis

Identifiers

PMID24031169
PMCPMC3768376
OpenAlexW2164972775

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.